SCHEMBL20107347

SCHEMBL20107347

CC(C)COP(=O)(OCC(C)C)SCC(C)O

nearest known ligand 0.37

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
LAP3 P28838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25670460 0.90 CYP3A4 (0.31) CYP3A4GAA
SCHEMBL6780032 0.85 ALDH1A1 (0.31) CYP3A4GAA
SCHEMBL9306932 0.76 ALDH1A1 (0.30)
SCHEMBL20107503 0.75 CTSA (0.36)
SCHEMBL20107459 0.74 LAP3 (0.34) LAP3
SCHEMBL17677605 0.74
SCHEMBL25670440 0.72 LAP3 (0.33) LAP3
SCHEMBL25670414 0.70
SCHEMBL8659098 0.69 CYP3A4 (0.33) CYP3A4GAAMEN1KMT2ALAP3
SCHEMBL18535411 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667866-B2 Phosphorous containing compounds and uses thereof AFTON CHEMICAL CORPORATION (US) 2023-06-06 US disclosed
US-11667866-B2 Phosphorous containing compounds and uses thereof AFTON CHEMICAL CORPORATION (US) 2023-06-06 US disclosed
US-20210355408-A1 Phosphorous Containing Compounds and Uses Thereof AFTON CHEMICAL CORP (US) 2021-11-18 US disclosed
US-11066619-B2 Phosphorous containing compounds and uses thereof AFTON CHEMICAL CORPORATION (US) 2021-07-20 US disclosed
US-20200056114-A1 Phosphorous Containing Compounds and Uses Thereof AFTON CHEMICAL CORP (US) 2020-02-20 US disclosed
WO-2018081822-A1 PHOSPHOROUS CONTAINING COMPOUNDS AND USES THEREOF AFTON CHEMICAL CORPORATION (US) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210355408-A1 Phosphorous Containing Compounds and Uses Thereof SOST, PHOSPHO1, PSPH CYP3A4 4745/4885GAA 3912/4885MEN1 1894/4885
US-20200056114-A1 Phosphorous Containing Compounds and Uses Thereof SOST, PHOSPHO1, PSPH CYP3A4 4745/4885GAA 3912/4885MEN1 1894/4885
US-11667866-B2 Phosphorous containing compounds and uses thereof SOST, PHOSPHO1, PSPH CYP3A4 4745/4885GAA 3912/4885MEN1 1894/4885
US-11066619-B2 Phosphorous containing compounds and uses thereof SOST, PHOSPHO1, PSPH CYP3A4 4745/4885GAA 3912/4885MEN1 1894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.